These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7626934)

  • 1. Drug therapy for patients with rheumatoid arthritis.
    Arthur V
    Br J Nurs; 1995 Jun 8-21; 4(11):616-21. PubMed ID: 7626934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatology. Part 2: The role of medication.
    Byrne J
    Prof Nurse; 1999 Feb; 14(5):353-8. PubMed ID: 10205553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: treating to target with disease-modifying drugs.
    Firth J
    Br J Nurs; 2011 Oct 28-Nov 9; 20(19):1240, 1242, 1244-5. PubMed ID: 22067836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating to target in rheumatoid arthritis: biologic therapies.
    Firth J; Critchley S
    Br J Nurs; 2011 Nov 10-23; 20(20):1284, 1287-8, 1290-1. PubMed ID: 22068002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
    Choy E
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
    Taniguchi A; Urano W; Tanaka E; Kamatani N
    Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of basic antirheumatic therapy].
    Keitel W
    Fortschr Med; 1994 Oct; 112(30):419-22. PubMed ID: 7806117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid disease.
    Subhash C; Agarwal AK; Rewari BB; Sangla KS; Vijay A
    J Assoc Physicians India; 1995 Mar; 43(3):232-3. PubMed ID: 11256928
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern treatment of rheumatoid arthritis].
    Surányi P
    Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug delivery system of anti-inflammatory and anti-rheumatic drugs].
    Kawai S
    Nihon Rinsho; 1998 Mar; 56(3):782-7. PubMed ID: 9549373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.